155 related articles for article (PubMed ID: 21763622)
41. Calcium signaling in pluripotent stem cells.
Apáti Á; Pászty K; Erdei Z; Szebényi K; Homolya L; Sarkadi B
Mol Cell Endocrinol; 2012 Apr; 353(1-2):57-67. PubMed ID: 21945604
[TBL] [Abstract][Full Text] [Related]
42. The adaptation of human embryonic stem cells to different feeder-free culture conditions is accompanied by a mitochondrial response.
Ramos-Mejia V; Bueno C; Roldan M; Sanchez L; Ligero G; Menendez P; Martin M
Stem Cells Dev; 2012 May; 21(7):1145-55. PubMed ID: 21671728
[TBL] [Abstract][Full Text] [Related]
43. Pinacidil enhances survival of cryopreserved human embryonic stem cells.
Barbaric I; Jones M; Buchner K; Baker D; Andrews PW; Moore HD
Cryobiology; 2011 Dec; 63(3):298-305. PubMed ID: 22027383
[TBL] [Abstract][Full Text] [Related]
44. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state.
Lin SL; Chang DC; Chang-Lin S; Lin CH; Wu DT; Chen DT; Ying SY
RNA; 2008 Oct; 14(10):2115-24. PubMed ID: 18755840
[TBL] [Abstract][Full Text] [Related]
45. Defined and serum-free media support undifferentiated human embryonic stem cell growth.
Chin AC; Padmanabhan J; Oh SK; Choo AB
Stem Cells Dev; 2010 Jun; 19(6):753-61. PubMed ID: 19686051
[TBL] [Abstract][Full Text] [Related]
46. Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O(6)-methylguanine due to high E2F1 regulated mismatch repair.
Roos WP; Christmann M; Fraser ST; Kaina B
Cell Death Differ; 2007 Aug; 14(8):1422-32. PubMed ID: 17464330
[TBL] [Abstract][Full Text] [Related]
47. Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: a dose-dependent effect of osterix over-expression.
Kärner E; Unger C; Cerny R; Ahrlund-Richter L; Ganss B; Dilber MS; Wendel M
J Cell Physiol; 2009 Feb; 218(2):323-33. PubMed ID: 18932205
[TBL] [Abstract][Full Text] [Related]
48. Primitive cardiac cells from human embryonic stem cells.
Hudson J; Titmarsh D; Hidalgo A; Wolvetang E; Cooper-White J
Stem Cells Dev; 2012 Jun; 21(9):1513-23. PubMed ID: 21933026
[TBL] [Abstract][Full Text] [Related]
49. Comparison of neural differentiation potential of human pluripotent stem cell lines using a quantitative neural differentiation protocol.
Yin D; Tavakoli T; Gao WQ; Ma W
Methods Mol Biol; 2012; 873():247-59. PubMed ID: 22528360
[TBL] [Abstract][Full Text] [Related]
50. Laminin-511 but not -332, -111, or -411 enables mouse embryonic stem cell self-renewal in vitro.
Domogatskaya A; Rodin S; Boutaud A; Tryggvason K
Stem Cells; 2008 Nov; 26(11):2800-9. PubMed ID: 18757303
[TBL] [Abstract][Full Text] [Related]
51. Cluster characterization of mouse embryonic stem cell-derived pluripotent embryoid bodies in four distinct developmental stages.
Qin J; Guo X; Cui GH; Zhou YC; Zhou DR; Tang AF; Yu ZD; Gui YT; Cai ZM
Biologicals; 2009 Aug; 37(4):235-44. PubMed ID: 19339198
[TBL] [Abstract][Full Text] [Related]
52. Propensity of human embryonic stem cell lines during early stage of lineage specification controls their terminal differentiation into mature cell types.
Pal R; Totey S; Mamidi MK; Bhat VS; Totey S
Exp Biol Med (Maywood); 2009 Oct; 234(10):1230-43. PubMed ID: 19546356
[TBL] [Abstract][Full Text] [Related]
53. Immunocytochemical analysis of human pluripotent stem cells using a self-made cytospin apparatus.
Pascual EY; Riggs MJ; Rao RR
J Vis Exp; 2010 Apr; (38):. PubMed ID: 20383120
[TBL] [Abstract][Full Text] [Related]
54. Notch promotes neural lineage entry by pluripotent embryonic stem cells.
Lowell S; Benchoua A; Heavey B; Smith AG
PLoS Biol; 2006 May; 4(5):e121. PubMed ID: 16594731
[TBL] [Abstract][Full Text] [Related]
55. HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.
Säljö K; Barone A; Mölne J; Rydberg L; Teneberg S; Breimer ME
Sci Rep; 2017 Oct; 7(1):13072. PubMed ID: 29026098
[TBL] [Abstract][Full Text] [Related]
56. Differentiation of neural lineage cells from human pluripotent stem cells.
Schwartz PH; Brick DJ; Stover AE; Loring JF; Müller FJ
Methods; 2008 Jun; 45(2):142-58. PubMed ID: 18593611
[TBL] [Abstract][Full Text] [Related]
57. Mouse ES cells maintained in different pluripotency-promoting conditions differ in their neural differentiation propensity.
Hirose H; Kato H; Kikuchi-Taura A; Soma T; Taguchi A
In Vitro Cell Dev Biol Anim; 2012 Mar; 48(3):143-8. PubMed ID: 22282341
[TBL] [Abstract][Full Text] [Related]
58. Expression and co-expression of surface markers of pluripotency on human amniotic cells cultured in different growth media.
Bryzek A; Czekaj P; Plewka D; Komarska H; Tomsia M; Lesiak M; Sieroń AL; Sikora J; Kopaczka K
Ginekol Pol; 2013 Dec; 84(12):1012-24. PubMed ID: 24505948
[TBL] [Abstract][Full Text] [Related]
59. Generation and trapping of a mesoderm biased state of human pluripotency.
Stavish D; Böiers C; Price C; Frith TJR; Halliwell J; Saldaña-Guerrero I; Wray J; Brown J; Carr J; James C; Barbaric I; Andrews PW; Enver T
Nat Commun; 2020 Oct; 11(1):4989. PubMed ID: 33020476
[TBL] [Abstract][Full Text] [Related]
60. Global MicroRNA Profiling Uncovers miR-206 as a Negative Regulator of Hematopoietic Commitment in Human Pluripotent Stem Cells.
Flamant S; Chomel JC; Desterke C; Féraud O; Gobbo E; Mitjavila-Garcia MT; Foudi A; Griscelli F; Turhan AG; Bennaceur-Griscelli A
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30965622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
